Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation
Top Cited Papers
- 22 January 2008
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 347 (1-2), 109-117
- https://doi.org/10.1016/j.ijpharm.2007.06.028
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nanotechnology: Intelligent Design to Treat Complex DiseasePharmaceutical Research, 2006
- Summary of recombinant human serum albumin developmentBiologicals, 2006
- Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.Clinical Cancer Research, 2006
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytesBiomaterials, 2005
- Optimization of the preparation process for human serum albumin (HSA) nanoparticlesInternational Journal of Pharmaceutics, 2003
- Pharmaceutical Strategies Utilizing Recombinant Human Serum AlbuminPharmaceutical Research, 2002
- Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptakeJournal of Microencapsulation, 2000
- Structure of Serum AlbuminAdvances in protein chemistry, 1994
- Atomic structure and chemistry of human serum albuminNature, 1992